Which are the symptoms of Smith-Lemli-Opitz Syndrome?

TL;DR: Smith-Lemli-Opitz syndrome (SLOS) is a genetic metabolic disorder characterized by a deficiency in the enzyme 7-dehydrocholesterol reductase, leading to an inability to synthesize cholesterol. Symptoms vary widely but typically include distinctive facial features, intellectual disability, developmental delays, and various physical malformations such as syndactyly (webbed toes) and genital abnormalities.

What are the primary symptoms of Smith-Lemli-Opitz syndrome?

Smith-Lemli-Opitz syndrome is a multisystem disorder, meaning its effects are widespread across the body. Because cholesterol is vital for cell membrane structure and signaling, a deficiency impacts nearly every organ system. The most common physical characteristics often identified at birth include microcephaly (a small head size), ptosis (drooping eyelids), a short, upturned nose, and micrognathia (a small jaw). Many individuals with Smith-Lemli-Opitz syndrome also exhibit 2-3 syndactyly of the toes, which is a hallmark clinical feature. Additionally, many patients experience significant failure to thrive, gastrointestinal issues like severe reflux or constipation, and genital malformations in males, such as hypospadias or undescended testes.

How does symptom severity vary in Smith-Lemli-Opitz syndrome?

The clinical spectrum of Smith-Lemli-Opitz syndrome is broad, ranging from very mild cases to severe, lethal presentations. This variability is largely dependent on the residual activity of the 7-dehydrocholesterol reductase enzyme. Patients with "mild" Smith-Lemli-Opitz syndrome may present with only minor physical anomalies and learning difficulties, whereas those with more severe enzyme deficiencies may experience profound intellectual disability, structural heart defects, and life-threatening metabolic instability during infancy.

Which symptoms impact daily quality of life the most?

For the 61 members of the DiseaseMaps.org community living with Smith-Lemli-Opitz syndrome, the most significant challenges often involve neurodevelopmental and behavioral symptoms. These include:

• Severe behavioral issues: Many individuals experience extreme irritability, self-injurious behaviors, and sleep disturbances.


• Developmental delays: Intellectual disability is common, ranging from mild to severe, often necessitating ongoing speech, occupational, and physical therapy.


• Feeding difficulties: Persistent gastrointestinal distress and refusal of food can make nutritional management a daily struggle for families.


• Sensory processing disorders: Hypersensitivity to stimuli can complicate social integration and school environments.

When should families seek immediate medical attention?

Because individuals with Smith-Lemli-Opitz syndrome are immunocompromised and prone to metabolic stress, caregivers must be vigilant. You should seek immediate medical evaluation if you observe signs of metabolic acidosis, unexplained lethargy, persistent vomiting, or signs of infection (such as a high fever), as these can quickly lead to severe complications in patients with Smith-Lemli-Opitz syndrome.

How do symptoms change as a patient ages?

While the physical malformations associated with Smith-Lemli-Opitz syndrome are typically present from birth, the focus of clinical care often shifts with age. In infancy, the primary concern is neonatal survival, feeding, and preventing metabolic crisis. As children reach school age, the focus shifts toward managing cognitive development and behavioral regulation. Long-term, adults with Smith-Lemli-Opitz syndrome may continue to require support for intellectual disabilities and, in some cases, may develop photosensitivity or cataracts.

Next steps

• Consult with a clinical geneticist to confirm a diagnosis through plasma sterol analysis.


• Reach out to the DiseaseMaps.org community to connect with other families navigating the challenges of Smith-Lemli-Opitz syndrome.


• Work with a metabolic specialist to discuss cholesterol supplementation and dietary management strategies.


• Seek early intervention programs for developmental therapies tailored to your child's specific needs.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): Smith-Lemli-Opitz syndrome.


• Orphanet: 7-dehydrocholesterol reductase deficiency (Smith-Lemli-Opitz syndrome).


• Online Mendelian Inheritance in Man (OMIM): Entry #270400 - Smith-Lemli-Opitz syndrome.


• Smith-Lemli-Opitz Foundation: Resource for families and clinical research updates.